Hypoxia-induced generation of nitric oxide free radicals in cerebral cortex of newborn guinea pigs

Neurochemical Research

Volumn 25, Issue 12, 2000, Pages 1559-1565

  Mishra, Om Prakash ^a   Zanelli, Santina ^a   Ohnishi, Tsuyoshi ^a   Delivoria Papadopoulos, M ^a  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

Brain; ESR; Hypoxia; Newborn; NO Free radicals; NOS

Indexed keywords

ADENOSINE TRIPHOSPHATE; CITRATE SODIUM; CREATINE PHOSPHATE; DIETHYLDITHIOCARBAMIC ACID; FREE RADICAL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; SUPEROXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN HYPOXIA; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; GUINEA PIG; NEUROTOXICITY; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; CEREBRAL CORTEX; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICALS; GUINEA PIGS; NITRIC OXIDE;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0034519396     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026610301978     Document Type: Article

References (68)

1. Nitric oxide: Physiology, pathophysiology and pharmacology
2. Nitric oxide and synaptic function
3. Peroxynitrite-induced membrane lipid oxidation, the cytotoxic potential of superoxide and nitric oxide
4. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse
5. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation
6. Analysis of the neuroprotective effect os of various nitric oxide donor compounds in murine cortical cell culture
7. Lipid free radical generation and brain cell membrane alteration following nitric oxide synthase inhibition during cerebral hypoxia in the newborn piglet
8. Nitric oxide mediates glutamate linked enhancement of cGMP levels in cerebellum
9. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices
10. Excitatory amino acid mediated cytotoxicity and calcium homeostasis incultured neurons
11. Excitatory amino acids as a final common pathway for neurologic disorders
12. NMDA receptor modification of the fetal guinea pig brain during hypoxia
13. Hypoxia-induced modification of the N-methyl-D-aspartate (NMDA) receptor in the brain of newborn piglets
14. Modification of the glycine (co-activator) binding site of the N-methyl-D-aspartate receptor in the guinea pig fetus brain during development following hypoxia
15. Effects of 3-(2-carboxy-piperzine-4-yl) propyl-1-phosphonic acid (CPP) on NMDA receptor binding characteristics and brain cell membrane function during cerebral hypoxia in newborn piglets
16. ++-modification of the NMDA receptor during graded hypoxia in cerebral cortex of newborn piglets
17. NMDA receptor mediated calcium influx in cerebral cortical synaptosomes of the hypoxic guinea pig fetus
18. Electron paramagnetic resonance (EPR) detection of nitric oxide produced during forebrain ischemia of the rat
19. Creatine Phosphate
20. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III)
21. Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung
22. 2
23. Regulation of cerebellar nitric oxide production in response to prolonged in vivo hypoxia
24. Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat
25. Nitric oxide synthase in models of focal ischemia
26. Cellular mechanisms of hypoxic injury in the developing brain
27. Calcium: Still center-stage in hypoxicischemic neuronal death
28. Calcium in ischemic cell death
29. Brain cytochromes and change in energy states
30. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria
31. Cerebral hypoxia: Some new approaches and unanswered questions
32. Glutamate and the pathophysiology of hypoxic-ischemic brain damage
33. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system
34. Blockade of N-methyl-D-aspartate receptors may protect against ischaemic damage in the brain
35. Glutamate antagonist therapy reduced neurologic deficits produced by focal central nervous system ischemia
36. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat
37. Focal cerebral ischemia in the cat: Pretreatment with a competitive NMDA receptor antagonist, D-CPPene
38. 3H]-(+)-MK-801 binding to rat brain sections by CPP and 7-chlorokyneuric acid: An autoradiographic analysis
39. Developmental differences in antagonism of NMDA toxicity by the polyamine site antagonist ifenprodil
40. 4 infusion on NMDA receptor binding characteristics during cerebral cortical hypoxic in the newborn piglet
41. Systemic administration of MK-801 protects against N-methyl-D-aspartate and quisquilate-mediated neurotoxicity in perinatal rats
42. Nitric oxide mediates glutamate neurotoxicity in primary cortical culture
43. Nitric oxidecellular regulation and neuronal injury
44. Effect of cerebral ischemia in mice deficient neuronal nitirc oxide synthase
45. Nitric oxide in health and diseases of the nervous system
46. Histochemical localization of nitric oxide neurons in the hypothalamus: Association with gonadotropin-relaeasing hormone neurons and co-localization with N-methyl-D-aspartate receptors
47. NMDA-R1 subunit of the cerebral cortex co-localizes with neuronal nitric oxide synthase at pre- and postsynaptic sites and in spines
48. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme
49. Endothelium derived relaxing factorrelease on activation of NMDA receptor suggests roles oas intracellular messenger in brain
50. Glutamate receptor agonists stimulate nitric oxide synthase in primary culture of cerebellar granule cells
51. Nitric oxide synthase in visual cortex of monocular monkey as revealed by light and electron microscopic immunochemistry
52. PSD-95 assembles a ternary complex with the N-methyl-D-aspartate receptor and a bivalent neuronal NO synthase PDZ domain
53. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein
54. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
55. Peroxynitrite formation from macrophage-derived nitric oxide
56. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
57. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide
58. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase
59. Kinetics of superoxide dismustase and iron-catalyzed nitration of phenolics by peroxynitrite
60. Excessive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry
61. Nitric oxide in health and disease of the nervous system
62. Protein nitration in Parkinson's Disease
63. Bright and dark sides of nitric oxide in ischemic brain injury
64. Peroxynitrite, superoxide dismutase, and tyrosine nitration in neurodegeneration
65. ALS, SOD and peroxynitrite
66. Evidence for neuronal oxidative damage in Alzheimer's disease
67. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine of hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant
68. Widespread peroxynitrite-mediated damage in Alzheimer's disease